Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes

Journal of Experimental Medicine

Volumn 189, Issue 5, 1999, Pages 767-777

  Chaux, Pascal ^a   Vantomme, Valérie ^a   Stroobant, Vincent ^a   Thielemans, Kris ^b   Corthals, Jurgen ^b   Luiten, Rosalie ^a   Eggermont, Alexander M M ^c   Boon, Thierry ^a   Van Der Bruggen, Pierre ^a,d  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

Histocompatibility leukocyte antigen class II; Human; Invariant chain; Peptide; Tumor

Indexed keywords

CD4 ANTIGEN; HLA DR ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGENICITY; ARTICLE; EPITOPE MAPPING; GENE EXPRESSION REGULATION; GENE ISOLATION; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; COCULTURE TECHNIQUES; DENDRITIC CELLS; EPITOPES; HLA-DR ANTIGENS; HUMANS; MALE; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDES;

EID: 0033103512     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.5.767     Document Type: Article

References (52)

1. Anichini, A., G. Fossati, and G. Parmiani. 1987. Clonal analysis of the cytolytic T-cell response to human tumors. Immunol Today. 8:385-389.
2. Hérin, M., C. Lemoine, P. Weynants, F. Vessière, A. Van Pel, A. Knuth, R. Devos, and T. Boon. 1987. Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer. 39:390-396.
3. De Plaen, E., K. Arden, C. Traversari, J.J. Gaforio, J.-P. Szikora, C. De Smet, F. Brasseur, P. van der Bruggen, B. Lethé, C. Lurquin, et al. 1994. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics. 40:360-369.
4. Van den Eynde, B., and P. van der Bruggen. 1997. T cell defined tumor antigens. Cur. Opin. Immunol. 9:684-693.
5. Takahashi, K., S. Shichijo, M. Noguchi, M. Hirohata, and K. Itoh. 1995. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 55:3478-3482.
6. Haas, G.G., Jr., O.J. D'Cruz, and L.E. De Bault. 1988. Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Am. J. Reprod. Immunol. Microbiol. 18:47-51.
7. Boël, P., C. Wildmann, M.-L. Sensi, R. Brasseur, J.-C. Renauld, P. Coulie, T. Boon, and P. van der Bruggen. 1995. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2:167-175.
8. Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689-698.
9. Lucas, S., C. De Smet, K.C. Arden, C.S. Viars, B. Lethé, C. Lurquin, and T. Boon. 1998. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res. 58:743-752.
10. Lethé, B., S. Lucas, L. Michaux, C. De Smet, D. Godelaine, A. Serrano, E. De Plaen, and T. Boon. 1998. LAGE-1, a new gene with tumor specificity. Int. J. Cancer. 76:903-908.
11. Sahin, U., O. Türeci, and M. Pfreundschuh. 1997. Serological identification of human tumor antigens. Curr. Opin. Immunol. 9:709-716.
12. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, E. De Plaen, B. Lethé, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes J. Exp. Med. 179:921-930.
13. Celis, E., V. Tsai, C. Crimi, R. DeMars, P.A. Wentworth, R.W. Chesnut, H.M. Grey, A. Sette, and H.M. Serra. 1994. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA. 91:2105-2109.
14. van der Bruggen, P., J. Bastin, T. Gajewski, P.G. Coulie, P. Boël, C. De Smet, C. Traversari, A. Townsend, and T. Boon. 1994. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24:3038-3043.
15. Kawashima, I., S. Hudson, V. Tsai, S. Southwood, K. Takesako, E. Appella, A. Sette, and E. Celis. 1998. The multiepitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum. Immunol. 59:1-14.
16. Tanaka, F., T. Fujie, K. Tahara, M. Mori, K. Takesako, A. Sette, E. Celis, and T. Akiyoshi. 1997. Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24. Cancer Res. 57:4465-4468.
17. Herman, J., P. van der Bruggen, I. Luescher, S. Mandruzzato, P. Romero, J. Thonnard, K. Fleischhauer, T. Boon, and P.G. Coulie. 1996. A peptide encoded by the human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics. 43:377-383.
18. - T cells. Tumor eradication does not require participation of cytotoxic T cells. J. Exp. Med. 161:1122-1134.
19. Grohmann, U., R. Bianchi, M.C. Fioretti, F. Fallarino, L. Binaglia, C. Uyttenhove, A. Van Pel, T. Boon, and P. Puccetti. 1995. CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum - or helper peptides in priming for skin test reactivity to a P815AB-related peptide. Eur. J. Immunol. 25:2797-2802.
20. Pulaski, B.A., and S. Ostrand-Rosenberg. 1998. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 58:1486-1493.
21. Ossendorp, F., E. Mengede, M. Camps, R. Filius, and C. Melief. 1998. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J. Exp. Med. 187:693-702.
22. Bosch, G.J., A.M. Joosten, J.H. Kessler, C.J. Melief, and O.C. Leeksma. 1996. Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Blood. 88:3522-3527.
23. Fossum, B., J. Breivik, G.I. Meling, T. Gedde-Dahl III, T. Hansen, I. Knutsen, T.O. Rognum, E. Thorsby, and G. Gaudernack. 1994. A K-ras 13Gly→Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation? Int. J. Cancer. 58:506-511.
24. + T cells recognize nonmu-tated HLA-DR-restricted tyrosinase epitopes. J. Exp. Med. 183:1965-1971.
25. + T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase. Cancer Res. 58:296-301.
26. Li, K., M. Adibzadeh, T. Halder, H. Kalbacher, S. Heinzel, C. Muller, J. Zeuthen, and G. Pawelec. 1998. Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells. Cancer Immunol. Immunother. 47:32-38.
27. L promoter: strategies for overproducing transcription termination factor p. Proc. Natl. Acad. Sci. USA. 82:88-92.
28. Riviere, I., K. Brose, and R.C. Mulligan. 1995. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA. 92:6733-6737.
29. Graham, F., and A. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 54:456-467.
30. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99-105.
31. Hansen, M.B., S.E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:203-210.
32. Traversari, C., P. van der Bruggen, B. Van den Eynde, P. Hainaut, C. Lemoine, N. Ohta, L. Old, and T. Boon. 1992. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics. 35:145-152.
33. Bodmer, J.G., S.G.E. Marsh, E.D. Albert, W.F. Bodmer, R.E. Bontrop, D. Charron, B. Dupont, H.A. Erlich, R. Fauchet, B. Mach, et al. 1997. Nomenclature for factors of the HLA system, 1996. Tissue Antigens. 49:297-321.
34. Engelhard, V.H. 1994. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12: 181-207.
35. Sanderson, S., K. Frauwirth, and N. Shastri. 1995. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins. Proc. Natl. Acad. Sci. USA. 92:7217-7221.
36. Nuchtern, J.G., W.E. Biddison, and R.D. Klausner. 1990. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature, 343:74-76.
37. Geuze, H.J. 1998. The role of endosomes and lysosomes in MHC class II functioning. Immunol. Today. 19:282-287.
38. Vijayasaradhi, S., Y. Xu, B. Bouchard, and A.N. Houghton. 1995. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75. J. Cell Biol. 130:807-820.
39. Topalian, S.L., L. Rivoltini, M. Mancini, N.R. Markus, P.F. Robbins, Y. Kawakami, and S.A. Rosenberg. 1994. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA. 91:9461-9465.
40. Chen, Y.-T., E. Stockert, Y. Chen, P. Garin-Chesa, W.J. Rettig, P. van der Bruggen, T. Boon, and L.J. Old. 1994. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc. Natl. Acad. Sci. USA. 91: 1004-1008.
41. Jurk, M., E. Kremmer, U. Schwarz, R. Forster, and E.L. Winnacker. 1998. MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus. Int. J. Cancer. 75:762-766.
42. Rovere, P., C. Vallinoto, A. Bondanza, M.C. Crosti, M. Rescigno, P. Ricciardi-Castagnoli, C. Rugarli, and A.A. Manfredi. 1998. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 161: 4467-4471.
43. Hoon, D.S., D. Yuzuki, M. Hayashida, and D.L. Morton. 1995. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J. Immunol. 154:730-737.
44. Chen, Y.T., A.O. Gure, S. Tsang, E. Stockert, E. Jager, A. Knuth, and L.J. Old. 1998. Identification of multiple cancer/ testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. USA. 95:6919-6923.
45. Marchand, M., N. van Baren, P. Weynants, V. Brichard, B. Dréno, M.-H. Tessier, E. Rankin, G. Parmiani, F. Arienti, Y. Humblet, et al. 1999. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer. 80:219-230.
46. Ridge, J.P., F. Di'Rosa, and P. Matzinger. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 393:474-478.
47. Schoenberger, S.P., R.E.M. Toes, E.I.H. van der Voort, R. Offringa, and C. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:480-483.
48. Bennett, S.R., F.R. Carbone, F. Karamalis, R.A. Flavell, J.F. Miller, and W.R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:478-480.
49. Lin, K.Y., F.G. Guarnieri, K.F. Staveley-O'Carroll, H.I. Levitsky, J.T. August, D.M. Pardoll, and T.C. Wu. 1996. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56:21-26.
50. Altman, J.D., P.A.H. Moss, P.J.R. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:94-96.
51. Romero, P., P. Rod Dunbar, D. Valmori, M. Pittet, G.S. Ogg, D. Rimoldi, J.L. Chen, D. Liénard, J.C. Cerottini, and V. Cerundolo. 1998. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188:1641-1650.
52. Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kappler. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 8:675-682.